# Myocardial Perfusion Assessment With Multidetector Computed Tomography

> **NCT00846079** · PHASE3 · UNKNOWN · sponsor: **Tennessee Heart and Vascular Institute, P.C.** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Regadenoson (Lexiscan) [muti-detector computed tomography]

## Key facts

- **NCT ID:** NCT00846079
- **Lead sponsor:** Tennessee Heart and Vascular Institute, P.C.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846079, "Myocardial Perfusion Assessment With Multidetector Computed Tomography". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00846079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*